Larry R. Miller | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Larry R. Miller is active.

Explore More

Publication

Featured researches published by Larry R. Miller.

Bioorganic & Medicinal Chemistry Letters | 2005

P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.

David G. Barrett; Virginia M. Boncek; John G. Catalano; David N. Deaton; Anne M. Hassell; Cynthia Holder Jurgensen; Stacey T. Long; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; J. Alan Payne; John A. Ray; Vicente Samano; Lisa M. Shewchuk; Francis X. Tavares; Kevin J. Wells-Knecht; Derril H. Willard; Lois L. Wright; Hui-Qiang Q. Zhou

Bioorganic & Medicinal Chemistry Letters | 2005

Novel and potent cyclic cyanamide-based cathepsin K inhibitors.

David N. Deaton; Anne M. Hassell; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; Lisa M. Shewchuk; Francis X. Tavares; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2004

Exploration of the P1 SAR of aldehyde cathepsin K inhibitors

John G. Catalano; David N. Deaton; Eric S. Furfine; A.M Hassell; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; Lisa M. Shewchuk; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2004

Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.

David G. Barrett; John G. Catalano; David N. Deaton; Anne M. Hassell; Stacey T. Long; Aaron B. Miller; Larry R. Miller; Lisa M. Shewchuk; Kevin J. Wells-Knecht; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2004

Design of small molecule ketoamide-based inhibitors of cathepsin K

John G. Catalano; David N. Deaton; Stacey T. Long; Robert B. McFadyen; Larry R. Miller; J. Alan Payne; Kevin J. Wells-Knecht; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2005

Acyclic cyanamide-based inhibitors of cathepsin K.

David G. Barrett; David N. Deaton; Anne M. Hassell; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; J. Alan Payne; Lisa M. Shewchuk; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2006

Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.

David G. Barrett; John G. Catalano; David N. Deaton; Anne M. Hassell; Stacey T. Long; Aaron B. Miller; Larry R. Miller; John A. Ray; Vicente Samano; Lisa M. Shewchuk; Kevin J. Wells-Knecht; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2004

Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K.

David G. Barrett; John G. Catalano; David N. Deaton; Stacey T. Long; Larry R. Miller; Francis X. Tavares; Kevin J. Wells-Knecht; Lois L. Wright; Hui-Qiang Q. Zhou

Bioorganic & Medicinal Chemistry Letters | 2006

Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?

Kim K. Adkison; David G. Barrett; David N. Deaton; Robert T. Gampe; Anne M. Hassell; Stacey T. Long; Robert B. McFadyen; Aaron B. Miller; Larry R. Miller; J. Alan Payne; Lisa M. Shewchuk; Kevin J. Wells-Knecht; Derril H. Willard; Lois L. Wright

Bioorganic & Medicinal Chemistry Letters | 2005